1.2780
+0.0040
+(0.31%)
At close: January 10 at 12:30:37 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 5 | 15 | 15 |
| Avg. Estimate | 34.52M | 632.2k | 38.53M | 9.95M |
| Low Estimate | 60k | 61k | 1.77M | -- |
| High Estimate | 97M | 1M | 97M | 42M |
| Year Ago Sales | 60.05M | 1.14M | 78.12M | 38.53M |
| Sales Growth (year/est) | -42.51% | -44.30% | -50.68% | -74.16% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 8EM.F | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Maintains | Evercore ISI Group: Outperform to Outperform | 12/16/2024 |
| Downgrade | JP Morgan: Neutral to Underweight | 12/16/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 12/13/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 12/13/2024 |
| Downgrade | Chardan Capital: Buy to Neutral | 12/13/2024 |
| Maintains | Baird: Outperform to Outperform | 12/13/2024 |
Related Tickers
BEAM Beam Therapeutics Inc.
26.39
-1.53%
DTIL Precision BioSciences, Inc.
5.70
+26.67%
ABCL AbCellera Biologics Inc.
2.9200
-3.63%
VRTX Vertex Pharmaceuticals Incorporated
409.56
-0.62%
DNA Ginkgo Bioworks Holdings, Inc.
9.78
-11.97%
REGN Regeneron Pharmaceuticals, Inc.
696.88
-5.00%
CRSP CRISPR Therapeutics AG
39.69
-3.88%
SANA Sana Biotechnology, Inc.
3.6600
-14.88%
MRNA Moderna, Inc.
42.25
-2.13%